NCT05757674

Brief Summary

Analysis of the Intestinal Microbiome in Patients With Wet Age-related Macular Degeneration

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
130

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2020

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2020

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

February 23, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

March 7, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 20, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 20, 2023

Completed
Last Updated

March 7, 2023

Status Verified

February 1, 2023

Enrollment Period

3.4 years

First QC Date

February 23, 2023

Last Update Submit

February 23, 2023

Conditions

Age-Related Macular Degeneration

Outcome Measures

Primary Outcomes (1)

  • Intestinal microbiome profile

    Intestinal microbiome profile

    2022-2023

Study Arms (2)

Patients

Patients

Other: Sample examination

Control

Control

Other: Sample examination

Interventions

Sample examinationOTHER

No intervention will be performed

ControlPatients

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Newly diagnosed patients with neovascular age-related macular degeneration from the area of North-West Greece

You may qualify if:

  • Newly diagnosed neovascular age-related macular degeneration.

You may not qualify if:

  • Chronic gastrointestinal disorders

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Ioannina

Ioannina, Epirus, 451 10, Greece

RECRUITING

University of Ioannina

Ioannina, Epirus, 45110, Greece

RECRUITING

MeSH Terms

Conditions

Macular Degeneration

Condition Hierarchy (Ancestors)

Retinal DegenerationRetinal DiseasesEye Diseases

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor of Ophthalmology

Study Record Dates

First Submitted

February 23, 2023

First Posted

March 7, 2023

Study Start

January 10, 2020

Primary Completion

June 20, 2023

Study Completion

June 20, 2023

Last Updated

March 7, 2023

Record last verified: 2023-02

Locations

GR(2)